These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29870599)

  • 1. Pharaceutical chemical characterization of ezetimibe.
    Blanka SS; Gabor O; Hajnal K
    Acta Pharm Hung; 2016; 86(4):133-139. PubMed ID: 29870599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal sterol transporters and cholesterol absorption inhibition.
    Davis HR; Tershakovec AM; Tomassini JE; Musliner T
    Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitosterol reduces messenger RNA and protein expression levels of Niemann-Pick C1-like 1 in FHs 74 Int cells.
    Jesch ED; Seo JM; Carr TP; Lee JY
    Nutr Res; 2009 Dec; 29(12):859-66. PubMed ID: 19963159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases.
    Pirillo A; Catapano AL; Norata GD
    Curr Med Chem; 2016; 23(10):983-99. PubMed ID: 26923679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
    Davis HR; Veltri EP
    J Atheroscler Thromb; 2007 Jun; 14(3):99-108. PubMed ID: 17587760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterol transporters: targets of natural sterols and new lipid lowering drugs.
    Sudhop T; Lütjohann D; von Bergmann K
    Pharmacol Ther; 2005 Mar; 105(3):333-41. PubMed ID: 15737409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.
    Knöpfel M; Davies JP; Duong PT; Kvaernø L; Carreira EM; Phillips MC; Ioannou YA; Hauser H
    Biochim Biophys Acta; 2007 Sep; 1771(9):1140-7. PubMed ID: 17689140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).
    Davis HR; Basso F; Hoos LM; Tetzloff G; Lally SM; Altmann SW
    Atheroscler Suppl; 2008 Sep; 9(2):77-81. PubMed ID: 18585981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol and plant sterol absorption: recent insights.
    von Bergmann K; Sudhop T; Lütjohann D
    Am J Cardiol; 2005 Jul; 96(1A):10D-14D. PubMed ID: 15992510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine.
    Nakano T; Inoue I; Takenaka Y; Ono H; Katayama S; Awata T; Murakoshi T
    PLoS One; 2016; 11(3):e0152207. PubMed ID: 27023132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niemann-Pick C1-Like 1 inhibitors for reducing cholesterol absorption.
    Zhang R; Liu W; Zeng J; Meng J; Jiang H; Wang J; Xing D
    Eur J Med Chem; 2022 Feb; 230():114111. PubMed ID: 35063734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of micelle characteristics on cholesterol absorption and ezetimibe inhibition: Insights from Niemann-Pick C1-like 1 binding and molecular structure.
    Aizawa H
    J Liposome Res; 2024 Sep; 34(3):386-398. PubMed ID: 37905576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(4):844-6. PubMed ID: 16188393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening for cholesterol absorption inhibitors.
    Sun L; Qian H; Huang W
    Med Chem; 2014; 11(1):2-12. PubMed ID: 24773346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ezetimibe (Ezetrol)].
    Scheen AJ
    Rev Med Liege; 2004 Apr; 59(4):246-50. PubMed ID: 15182038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Niemann-Pick C1-Like 1 by Ezetimibe Reduces Dietary 5β,6β-Epoxycholesterol Absorption in Rats.
    Shirouchi B; Furukawa Y; Nakamura Y; Kawauchi A; Imaizumi K; Oku H; Sato M
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):35-44. PubMed ID: 30671747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles.
    Labonté ED; Howles PN; Granholm NA; Rojas JC; Davies JP; Ioannou YA; Hui DY
    Biochim Biophys Acta; 2007 Sep; 1771(9):1132-9. PubMed ID: 17442616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
    Sweeney ME; Johnson RR
    Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):441-50. PubMed ID: 17539750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.